Erkelens CA - Search Results

1

The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts.

Houba PH, Boven E, Erkelens CA, Leenders RG, Scheeren JW, Pinedo HM, Haisma HJ. Houba PH, et al. Among authors: erkelens ca. Br J Cancer. 1998 Dec;78(12):1600-6. doi: 10.1038/bjc.1998.729. Br J Cancer. 1998. PMID: 9862570 Free PMC article.

2

BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts.

Boven E, Verschraagen M, Hulscher TM, Erkelens CA, Hausheer FH, Pinedo HM, van der Vijgh WJ. Boven E, et al. Among authors: erkelens ca. Eur J Cancer. 2002 May;38(8):1148-56. doi: 10.1016/s0959-8049(02)00036-9. Eur J Cancer. 2002. PMID: 12008205

3

The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts.

Boven E, Hendriks HR, Erkelens CA, Pinedo HM. Boven E, et al. Among authors: erkelens ca. Br J Cancer. 1992 Dec;66(6):1044-7. doi: 10.1038/bjc.1992.407. Br J Cancer. 1992. PMID: 1457343 Free PMC article.

4

Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancer.

Boven E, Schlüper HM, Erkelens CA, Pinedo HM. Boven E, et al. Among authors: erkelens ca. Eur J Cancer. 1990;26(9):983-6. doi: 10.1016/0277-5379(90)90626-5. Eur J Cancer. 1990. PMID: 2149026

5

Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.

Boven E, Erkelens CA, Luning M, Pinedo HM. Boven E, et al. Among authors: erkelens ca. Br J Cancer. 1990 May;61(5):709-11. doi: 10.1038/bjc.1990.159. Br J Cancer. 1990. PMID: 2337508 Free PMC article. No abstract available.

6

Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer.

Boven E, Venema-Gaberscek E, Erkelens CA, Bissery MC, Pinedo HM. Boven E, et al. Among authors: erkelens ca. Ann Oncol. 1993 Apr;4(4):321-4. doi: 10.1093/oxfordjournals.annonc.a058491. Ann Oncol. 1993. PMID: 8100146 Free article.

7

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer.

Boven E, Schipper H, Erkelens CA, Hatty SA, Pinedo HM. Boven E, et al. Among authors: erkelens ca. Br J Cancer. 1993 Jul;68(1):52-6. doi: 10.1038/bjc.1993.285. Br J Cancer. 1993. PMID: 8318420 Free PMC article.

8

Anti-tumor activity of CPT-11 in experimental human ovarian cancer and human soft-tissue sarcoma.

Jansen WJ, Kolfschoten GM, Erkelens CA, Van Ark-Otte J, Pinedo HM, Boven E. Jansen WJ, et al. Among authors: erkelens ca. Int J Cancer. 1997 Dec 10;73(6):891-6. doi: 10.1002/(sici)1097-0215(19971210)73:6<891::aid-ijc22>3.0.co;2-6. Int J Cancer. 1997. PMID: 9399672

9

Characterization of human soft-tissue sarcoma xenografts for use in secondary drug screening.

Boven E, Pinedo HM, van Hattum AH, Scheffer PG, Peters WH, Erkelens CA, Schlüper HM, Kuiper CM, van Ark-Otte J, Giaccone G. Boven E, et al. Among authors: erkelens ca. Br J Cancer. 1998 Dec;78(12):1586-93. doi: 10.1038/bjc.1998.727. Br J Cancer. 1998. PMID: 9862568 Free PMC article.

10

Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.

Kolfschoten GM, Pinedo HM, Scheffer PG, Schlüper HM, Erkelens CA, Boven E. Kolfschoten GM, et al. Among authors: erkelens ca. Gynecol Oncol. 2000 Mar;76(3):362-8. doi: 10.1006/gyno.1999.5689. Gynecol Oncol. 2000. PMID: 10684711

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters